Wise closes $34.8M Series D to support neurostim tech
Summary
Wise has closed a $34.8 million Series D round to support its neurostimulation technology. The limited article text does not provide additional operational details, investors, or commercialization plans. The headline still makes the financing event clear enough to classify the item as funding. The company appears to operate in the health technology space rather than in consumer hardware or general tech.
Funding
Amount
$34.8M
Total raised
Date
June 17, 2026
Announcement date
Investors
WISE
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected